| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
APOA1
|
apolipoprotein A-I
|
|
ARHGAP31
|
Rho GTPase activating protein 31
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
C3
|
complement component 3
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCND1
|
cyclin D1
|
|
CD22
|
CD22 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CDC37
|
cell division cycle 37
|
|
CDCA7
|
cell division cycle associated 7
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK16
|
cyclin-dependent kinase 16
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLU
|
clusterin
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREM
|
cAMP responsive element modulator
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTPS1
|
CTP synthase 1
|
|
CTPS2
|
CTP synthase 2
|
|
CTTN
|
cortactin
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
DIAPH3
|
diaphanous-related formin 3
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP16
|
dual specificity phosphatase 16
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
ECT2
|
epithelial cell transforming 2
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF2S2
|
eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF5
|
eukaryotic translation initiation factor 5
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELK4
|
ELK4, ETS-domain protein (SRF accessory protein 1)
|
|
ENO1
|
enolase 1, (alpha)
|
|
EPOR
|
erythropoietin receptor
|
|
ESR1
|
estrogen receptor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GATA4
|
GATA binding protein 4
|
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12
|
|
GOLGA3
|
golgin A3
|
|
GORASP1
|
golgi reassembly stacking protein 1, 65kDa
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTF2I
|
general transcription factor IIi
|
|
H2AFX
|
H2A histone family, member X
|
|
HDAC4
|
histone deacetylase 4
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HTT
|
huntingtin
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK1
|
Janus kinase 1
|
|
JDP2
|
Jun dimerization protein 2
|
|
JUN
|
jun proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KRT17
|
keratin 17, type I
|
|
LEPR
|
leptin receptor
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
MAF1
|
MAF1 homolog (S. cerevisiae)
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK15
|
mitogen-activated protein kinase 15
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MOK
|
MOK protein kinase
|
|
MSN
|
moesin
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MXD1
|
MAX dimerization protein 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYOCD
|
myocardin
|
|
MYOD1
|
myogenic differentiation 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NME3
|
NME/NM23 nucleoside diphosphate kinase 3
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLN
|
phospholamban
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAR2A
|
protein kinase, cAMP-dependent, regulatory, type II, alpha
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PRL
|
prolactin
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTTG2
|
pituitary tumor-transforming 2
|
|
PXN
|
paxillin
|
|
PYGB
|
phosphorylase, glycogen; brain
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RET
|
ret proto-oncogene
|
|
RGCC
|
regulator of cell cycle
|
|
RHOU
|
ras homolog family member U
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
SFN
|
stratifin
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGK2
|
serum/glucocorticoid regulated kinase 2
|
|
SGK3
|
serum/glucocorticoid regulated kinase family, member 3
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC1A6
|
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SPACA1
|
sperm acrosome associated 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPSB1
|
splA/ryanodine receptor domain and SOCS box containing 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STK11
|
serine/threonine kinase 11
|
|
STX17
|
syntaxin 17
|
|
TBC1D1
|
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TH
|
tyrosine hydroxylase
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSPYL2
|
TSPY-like 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
|
USF1
|
upstream transcription factor 1
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VTN
|
vitronectin
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
